Facebook 6.1% CAGR Forecast: Strategic Analysis of Hypoprothrombinemia Treatment for Hematologists, Rare Disease Drug Developers, and Orphan Drug Investors
Logo

6.1% CAGR Forecast: Strategic Analysis of Hypoprothrombinemia Treatment for Hematologists, Rare Disease Drug Developers, and Orphan Drug Investors

クレジット
Avatar
Illustrator
6.1% CAGR Forecast: Strategic Analysis of Hypoprothrombinemia Treatment for Hematologists, Rare Disease Drug Developers, and Orphan Drug Investors-1
シェア
zozo linの他の作品